Cornea and External Disease
Latest news on corneal and external eye disorders, including infectious, inflammatory, and degenerative conditions. Coverage spans diagnostics, medical and surgical management, and emerging therapies.
Phase 3 trial of cenegermin-bkbj for PCED enrolls first US patient
The first patient in the United States has been dosed in a Phase 3 clinical trial evaluating cenegermin-bkbj ophthalmic solution for the...
Cornea specialists identify key clinical signs linked to microbial keratitis subtypes
United States cornea specialists identified a limited set of clinical features they believe reliably distinguish microbial keratitis (MK) organism groups, according to...
Preventing complications of superficial keratectomy
The contents of this article are informational only and are not intended to be a substitute for professional medical advice, diagnosis, or...
Latest Cornea and External Disease Videos
Cornea Day highlights at AAO 2025
Samantha Arsenault, MD, of the Henry Ford Health System, offered her feedback on highlights from AAO 2025, specifically the interesting findings from Cornea Day. Samantha Arsenault, MD: Hi, I’m Sam...
AS-OCT facilitates earlier intervention and improved outcomes post-corneal transplant
Sotiria Palioura, MD, MSc, PhD, of the Bascom Palmer Eye Institute, spoke at AAO 2025 about a study assessing the long-term monitoring of corneal grafts using anterior segment OCT pachymetry...
Eight-year findings from the Low-Concentration Atropine for Myopia Progression Study
Jason Yam, MD, of the Chinese University of Hong Kong, spoke at AAO 2025 about the LAMP1 study, which assessed the safe and optimal way to discontinue atropine treatment for...
Cryopreserved amniotic membrane after epi-off corneal crosslinking reduces postoperative complications
Reena Gupta, MD, of Omni Eye Services in New Jersey, spoke at AAO 2025 about her study that found utilization of amniotic membrane prevented complications post-corneal crosslinking procedure. Reena Gupta,...
FDA approves Epioxa, a first topical treatment for keratoconus
Glaukos Corporation announced the United States Food and Drug Administration has approved Epioxa HD / Epioxa, a topical, incision-free therapy for keratoconus, according to a press release. The treatment strengthens...
Study identifies risk factors for corneal crosslinking failure in keratoconus
Corneal crosslinking (CXL) is generally effective for stabilizing keratoconus, but a small percentage of patients are more likely to experience treatment failure and may require repeat crosslinking or corneal transplantation,...
Povidone-iodine and corneal collagen cross-linking show similar outcomes in resistant corneal ulcers
Both 1% povidone-iodine and corneal collagen cross-linking (CXL) are effective and equally viable options for treating corneal ulcers that do not respond to standard therapy, with no significant difference in...
DefEYE Inc launches as independent ophthalmic biologics company
DefEYE Inc, a privately held ophthalmic biologics company, has officially launched as an independent entity, focusing on decellularized biologic solutions for eye care, according to a press release. Previously part...